StockNews.AI
QSI
StockNews.AI
188 days

Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

1. Quantum-Si will report Q4 and FY 2024 financial results on March 3, 2025. 2. CEO Jeff Hawkins and CFO Jeff Keyes will host a results conference call. 3. The event emphasizes Quantum-Si’s focus on advancing proteomics.

Earnings
+6.27%Current Return
VS
+1.66%S&P 500
$1.9202/12 08:56 AM EDTEvent Start
$2.040302/13 03:31 PM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Neutral?

The upcoming financial results do not suggest immediate price movement, similar to past earnings announcements.

How important is it?

Upcoming earnings report is crucial for assessing QSI's performance and future direction.

Why Long Term?

Potential growth in proteomics could enhance QSI’s long-term valuation, similar to industry trends.

Related Companies

QSI
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will report financial results for the fourth quarter and full year 2024 on Monday, March 3, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will be available for replay following the event. About Quantum-Si Incorporated Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® line of instruments enables Next-Gen Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

Related News